A series on the good pediatric medicines that are ready to finish — and the bridge that carries them to the children waiting. The science is sound and the companies are extraordinary; we build the last mile the economics can't reach.
The Entries
Big science. Small patient population.
A good medicine looking for the right home.
High science. Too complex or costly to make at a profit.
Good science, parked in a reshuffle — never restarted.
Approved and ready — it just needs the last-mile push.